NVIDIA Healthcare Launches Generative AI Microservices for Drug Discovery
HIT Consultant
MARCH 18, 2024
These microservices, with 25 newly launched offerings, are poised to expedite healthcare workflows in drug discovery, medical imaging, and genomics analysis. Cadence, a computational software leader, integrates NVIDIA BioNeMo microservices into its Orion molecular design platform, enhancing drug discovery capabilities.
Let's personalize your content